Description: ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Home Page: www.shockwavemedical.com
SWAV Technical Analysis
5403 Betsy Ross Drive
Santa Clara,
CA
95054
United States
Phone:
510 279 4262
Officers
| Name | Title |
|---|---|
| Mr. Douglas E. Godshall M.B.A. | Pres, CEO & Director |
| Mr. Daniel Puckett MBA | CFO, Principal Financial Officer & Sec. |
| Mr. Isaac Zacharias | Chief Commercial Officer |
| Mr. Daniel Hawkins | Founder and Sr. Advisor |
| Mr. John M. Adams | Co-Founder and Technical Advisor |
| Mr. Mike Maszy | VP of Operations |
| Ms. Trinh Phung | Chief Accounting Officer, Principal Accounting Officer & VP of Fin. |
| Ms. Debbie Kaster | VP of Investor Relations |
| Mr. Hajime Tada J.D. | Gen. Counsel & Sec. |
| Mr. Rob Williamson Jr. | VP of Sales |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 61.7284 |
|---|---|
| Trailing PE: | 79.0873 |
| Price-to-Book MRQ: | 22.3954 |
| Price-to-Sales TTM: | 17.2956 |
| IPO Date: | 2019-03-07 |
| Fiscal Year End: | December |
| Full Time Employees: | 657 |